US Stock MarketDetailed Quotes

ALNY Alnylam Pharmaceuticals

Watchlist
  • 256.450
  • -8.440-3.19%
Close Feb 14 16:00 ET
  • 255.810
  • -0.640-0.25%
Pre 04:57 ET
33.20BMarket Cap-117.64P/E (TTM)

About Alnylam Pharmaceuticals Company

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Company Profile

SymbolALNY
Company NameAlnylam Pharmaceuticals
Listing DateMay 27, 2004
Issue Price6.00
Founded2002
CEODr. Yvonne L Greenstreet, MB.Ch.B.
MarketNASDAQ
Employees2230
Fiscal Year Ends12-31
Address675 West Kendall Street,Henri A. Termeer Square
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-551-8200
Websitehttp://www.alnylam.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Yvonne L Greenstreet, MB.Ch.B.
  • Director and Chief Executive Officer
  • 8.90M
  • Dr. Pushkal P. Garg, M.D.
  • Chief Medical Officer and Executive Vice President, Development and Medical Affairs
  • 3.23M
  • Kevin Joseph Fitzgerald, PhD
  • Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development
  • --
  • Dr. Akshay K. Vaishnaw, M.D.,PhD
  • Chief Innovation Officer
  • 3.32M
  • Jeffrey V. Poulton
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.22M
  • Tolga Tanguler
  • Chief Commercial Officer
  • 2.87M
  • Amy W. Schulman
  • Chairman of the Board
  • 531.36K
  • Michael W. Bonney
  • Director
  • 467.23K
  • Dr. Olivier Raymond Brandicourt, M.D.
  • Independent Director
  • 480.96K
  • Colleen F. Reitan
  • Independent Director
  • 489.15K
  • Peter N. Kellogg
  • Independent Director
  • 658.72K
  • Dr. Phillip A. Sharp,PhD
  • Independent Director
  • 502.21K
  • Dr. Carolyn R. Bertozzi, PhD
  • Independent Director
  • 668.94K
  • Dr. Dennis A. Ausiello, M.D.
  • Independent Director
  • 477.21K
  • Dr. Elliott Sigal, M.D.,PhD
  • Independent Director
  • 470.11K
  • Dr. Margaret A. Hamburg, M.D.
  • Independent Director
  • 471.39K
  • David E.I. Pyott, M.B.A.,M.D.
  • Independent Director
  • 477.21K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!